Private Label Tranexamic Acid Body Milk Manufacturer Low MOQ

Minimum order quantities for private label tranexamic acid body milk vary significantly depending on whether you choose a stock (white-label) formula or a fully custom development. For stock formulas where a manufacturer already holds a TXA emulsion base, MOQs typically start at 200–500 units per SKU. These are finished, filled, and labeled products ready for your branding. For semi-custom or custom formulas — where a cosmetic chemist adjusts the TXA concentration, fragrance, or additional actives to your specification — MOQs usually begin at 500–1,000 units. This threshold exists because custom batches require dedicated equipment runs, raw material procurement minimums, and QC testing that cannot be absorbed economically at very low volumes. Full custom development with novel ingredient combinations or advanced delivery systems (encapsulated TXA, liposomal TXA) typically carries MOQs of 1,000–2,500+ units, as the development investment requires more units to amortize costs. Several factors can push MOQs lower: manufacturers based in Southeast Asia (particularly South Korea, Taiwan, and China) often accommodate 200-unit runs for stock formulas due to lower labour costs and high production throughput. US and EU-based manufacturers with GMP facilities generally set higher MOQs of 500–1,000 units to cover compliance overhead. The most common mistake first-time founders make is negotiating MOQ without confirming what is actually included. A quoted MOQ of 300 units sometimes means 300 units of bulk product — not filled and labeled. Always confirm the MOQ refers to finished, shelf-ready units. Using a platform like AJ Cosmo Labs, you can filter manufacturers in the cosmetics marketplace by MOQ range, so you only spend time speaking with suppliers who can realistically serve your launch-stage business.

The total cost to private label a tranexamic acid body milk has three distinct components: development costs, per-unit manufacturing costs, and packaging costs. Understanding each separately prevents budget surprises. Development fees cover formulation work, stability testing (accelerated 3-month at 40°C/75% RH is standard), micro testing (preservative efficacy, total aerobic plate count), and safety data compilation. These range from $500 for a light adaptation of a stock formula to $3,000–$5,000 for a fully bespoke formula with a qualified cosmetic chemist. Some low-MOQ manufacturers waive development fees if your first production order meets a minimum threshold, often 500–1,000 units. Per-unit manufacturing cost (formulation, filling, and primary packaging) varies by run size and TXA concentration. At 200–500 units, expect $4–$7 per unit for a stock formula. At 500–2,000 units, cost-per-unit drops to $5–$10 for custom formulas. Runs above 2,500 units can bring per-unit cost to $3–$6 depending on the manufacturer's location and facility. Packaging — pumps, bottles, tubes, and secondary cartons — is often quoted separately. A 200ml HDPE pump bottle in an unbranded white-label format costs roughly $0.40–$0.80 per unit at low volumes. Custom-printed or premium-finish packaging adds $0.80–$2.50 per unit. Label printing for small runs (200–500 units) via digital label printers typically runs $0.15–$0.50 per label. At 2,000+ units, flexographic printing drops that to under $0.10 per label. Totaling these, a realistic landed cost for a 300-unit run of private label TXA body milk (200ml, pump bottle, stock formula, digital labels) is approximately $7–$10 per unit before your own shipping and duties. At 1,000 units custom, $6–$9 per unit is achievable. AJ Cosmo Labs helps founders get multiple quotes side by side so you can benchmark real market rates before committing.

Lead time for a custom tranexamic acid body milk follows a predictable sequence of stages, each with its own minimum duration. Founders who understand the pipeline avoid the mistake of promising a launch date before production is even started. Stage 1 — Brief and supplier selection: 1–2 weeks. This is the time from posting your product brief to selecting a manufacturer and signing a development agreement. Using a pre-vetted network like AJ Cosmo Labs compresses this stage significantly. Stage 2 — Formulation development: 2–6 weeks. For a stock TXA body milk formula, this stage may be skipped or reduced to minor adjustments (1–2 weeks). For a semi-custom formula — changing TXA concentration, adding complementary actives like niacinamide or alpha-arbutin, or adjusting skin feel — expect 3–6 weeks for a cosmetic chemist to develop and internally validate the formula. Stage 3 — Prototype sampling and evaluation: 1–3 weeks. The manufacturer produces lab-scale or pilot-scale samples (typically 200–500g jars of bulk). You evaluate skin feel, colour, fragrance, and spreadability. Most projects require 1–3 rounds of revision, which can add 2–4 weeks if changes are requested. Stage 4 — Stability and micro testing: 4–8 weeks. Accelerated stability (4 weeks at 40°C/75% RH) is the minimum industry standard for a new formula before bulk production. Micro testing (preservative efficacy, total plate count) typically takes 2–4 weeks and can run in parallel with stability. Stage 5 — Packaging procurement: 4–8 weeks. Custom-printed bottles or tubes with your branding can take 4–8 weeks from order to delivery, and this is often the longest lead item. Plan this in parallel with testing, not after. Stage 6 — Bulk production and filling: 1–4 weeks. Once formula is approved and packaging is on hand, filling a run of 500–1,000 units typically takes 1–2 weeks. Larger runs or shared production schedules can extend this. Total realistic timeline: 8–14 weeks for a semi-custom formula with diligent project management. Full custom development from scratch: 16–24 weeks. The most common delay is founders waiting on packaging procurement after formula approval, adding 6–8 weeks unnecessarily. Order your packaging the moment you advance to the stability testing stage.

Tranexamic acid (INCI: Tranexamic Acid) is used in cosmetic body care formulations at concentrations ranging from 1% to 5%, with 2–3% being the most common range for body milks targeting hyperpigmentation and uneven skin tone. The mechanism of action is well-established: TXA inhibits the interaction between keratinocytes and melanocytes by blocking plasminogen activator in keratinocytes, which in turn reduces UV-induced prostaglandin synthesis and melanin production. At cosmetic use levels (under 5%), tranexamic acid has a strong safety profile. It does not carry the sensitisation risk of kojic acid, the irritation potential of AHAs, or the regulatory restrictions of hydroquinone. The Cosmetic Ingredient Review (CIR) has reviewed tranexamic acid and cosmetic industry safety assessments generally support its use at up to 3–5% in leave-on products. For body milk specifically, a lightweight oil-in-water emulsion (body milk texture) is an excellent delivery vehicle because it allows high water-phase loading of TXA, spreads evenly over large body surface areas, and absorbs quickly without occlusion. The formula's pH must be maintained between 5.5 and 7.0 to ensure TXA stability; outside this range, degradation can occur, reducing efficacy. Common companion actives in TXA body milks include niacinamide (at 2–5%), alpha-arbutin (1–2%), and vitamin C derivatives — each addressing hyperpigmentation through a different pathway, creating a multi-modal brightening effect. Formulators often include a broad-spectrum antioxidant system to protect TXA from oxidative degradation in the finished formula. From a regulatory standpoint, TXA at cosmetic concentrations is classified as a cosmetic ingredient globally — not a drug — provided the brand makes only cosmetic-level claims. Brands must not claim the product 'treats' or 'cures' melasma, which would constitute a drug claim in the US under FDA jurisdiction. When briefing a manufacturer through AJ Cosmo Labs, specifying your target TXA concentration alongside your desired claim direction helps the cosmetic chemist select the right base formula and supporting actives from the outset.

Finding a vetted manufacturer for a specialty active like tranexamic acid body milk — especially at low MOQs that suit a small or emerging brand — is genuinely one of the hardest parts of launching a skin-care product. The challenge is not that TXA manufacturers don't exist; it is that most directories list manufacturers without verifying their capabilities, GMP status, or willingness to work at small scale. The conventional routes include trade shows (Cosmoprof, MakeUp in Paris, BeautyWorld Middle East), industry directories (SpecialChem, ThomasNet, CDMO databases), and cold outreach to contract manufacturers found through web searches. These approaches work, but typically take 3–6 months of evaluation before you have even a provisional manufacturing partner. When evaluating any manufacturer, require the following before proceeding: a current ISO 22716 certificate or equivalent GMP certification, a certificate of analysis for their tranexamic acid raw material, a formulation brief or existing TXA product data sheet, accelerated stability data for at least one TXA emulsion product, and references from at least two other indie brand clients. Disqualifying red flags include: inability to provide COAs for actives, no in-house cosmetic chemist (formulators who outsource their own formulation work are a high risk), vague or inconsistent answers about lead time and MOQ, no written contract terms, and requests for 100% upfront payment without milestone structure. Geographically, South Korea is the dominant low-MOQ TXA body milk hub due to its deeply developed K-beauty supply chain. South Korean ODM (original design manufacturer) factories routinely handle TXA emulsions at 200–300 unit MOQs with 8–12 week timelines. China, Taiwan, and increasingly India also have capable low-MOQ manufacturers. US-based manufacturers are more expensive but offer regulatory proximity for MoCRA compliance and faster sample shipping. AJ Cosmo Labs was built specifically to solve this discovery problem for indie founders. Download the iOS app, post a brief describing your TXA body milk concept, target MOQ, and budget, and receive responses from cosmetic manufacturers who have been vetted on the platform. You can message suppliers directly, review their capabilities, and release escrowed payments at milestones — all without leaving the app. It is the fastest way for a small brand to find a qualified manufacturing partner without spending months on cold outreach.

The certifications required from a tranexamic acid body milk manufacturer depend on your target markets and brand positioning, but a core set applies to virtually every serious commercial launch. ISO 22716 (GMP for Cosmetics) is the non-negotiable baseline. This international standard governs personnel, premises, equipment, raw materials, production, finished products, quality control, and documentation in cosmetic manufacturing facilities. Any manufacturer that cannot produce a current ISO 22716 certificate should be disqualified immediately for commercial production intended for retail sale. FDA Cosmetic Facility Registration is relevant for manufacturers selling into the US market. Under MoCRA (enacted December 2022), cosmetic manufacturing facilities must register with the FDA and list their products. While this does not confer FDA 'approval,' it demonstrates compliance intent and is increasingly required by US retailers and e-commerce platforms. For brands targeting the European Union, the manufacturer should be able to support the preparation of a Cosmetic Product Safety Report (CPSR) conducted by a qualified EU Safety Assessor, and a Product Information File (PIF) maintained by the EU Responsible Person. The manufacturer does not need to be EU-based, but must be able to supply the technical documentation necessary for these filings. For brands with sustainability or natural positioning, third-party certifications such as COSMOS (for natural/organic cosmetics), Leaping Bunny or PETA (cruelty-free), and Ecocert (natural ingredients) may be relevant. These require the manufacturer to source certified raw materials and maintain chain-of-custody documentation. For brands targeting the UK post-Brexit, the manufacturer must be able to support UK Responsible Person requirements, which are substantively similar to EU requirements. ISO 9001 (quality management systems) is a broader certification some manufacturers hold alongside ISO 22716. It is a positive signal but does not replace GMP certification. Microbial testing capabilities — either in-house or via a contracted ISO 17025-accredited laboratory — are essential. Ask specifically whether micro testing on finished TXA body milk batches is included in the quoted manufacturing price or billed separately. When using AJ Cosmo Labs to source manufacturers, you can include certification requirements in your product brief so only qualifying suppliers respond — saving you the time of manually screening unqualified partners.

Yes, and most successful TXA body milk formulas on the market today are multi-active systems rather than single-ingredient products. The rationale is straightforward: hyperpigmentation has multiple biological pathways, and targeting more than one pathway simultaneously produces visibly better results and a stronger product story for marketing. Niacinamide (vitamin B3) is the most popular companion to TXA. At 2–5%, niacinamide inhibits the transfer of melanosomes from melanocytes to keratinocytes — a different step from TXA's mechanism — and also improves skin barrier function, reduces transepidermal water loss, and has anti-inflammatory properties. The combination of TXA and niacinamide at clinically-supported concentrations is well-tolerated, chemically compatible, and widely used in K-beauty body care. Alpha-arbutin at 0.5–2% is a biosynthetic melanin synthesis inhibitor that works by reversibly inhibiting tyrosinase. It is more stable than beta-arbutin and more potent at lower concentrations. It is water-soluble and easily incorporated into the aqueous phase alongside TXA. Azelaic acid at 2–5% provides dual-action: tyrosinase inhibition and mild keratolytic activity to improve skin texture. It is especially useful in body milks targeting post-inflammatory hyperpigmentation from conditions like keratosis pilaris. Vitamin C derivatives — sodium ascorbyl phosphate (SAP) or ascorbyl glucoside — at 1–3% add antioxidant protection and additional melanin suppression. Pure L-ascorbic acid is generally too unstable for body milk applications, but stabilised derivatives work well. Panthenol (provitamin B5) at 0.5–2% is not a brightening active per se but is commonly included for its skin-conditioning, moisture-retention, and anti-inflammatory properties, which complement a brightening formula targeting post-inflammatory marks. Formulation compatibility is the key constraint. Your cosmetic chemist must verify that the pH required for TXA stability (5.5–7.0) is compatible with the other actives in the formula. Some actives, like L-ascorbic acid, prefer a much lower pH (3.0–3.5) and would not be compatible in the same phase. Stabilised vitamin C derivatives are selected precisely to avoid this conflict. When briefing a manufacturer through the AJ Cosmo Labs app, list your desired active combination and target concentrations alongside your TXA specification. A cosmetic chemist on the platform can advise on compatibility, optimal pH, and realistic cost impact of each additional active before you commit to development.